Xanthine epoxides as A.sub.1 adenosine receptor agonists and antagonists
US5631260A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1994 |
| Grant date | May 20, 1997 |
| Priority date | — |
| Expiry date | Oct 28, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Xanthine derivatives, and compositions comprising those compounds, are potent selective antagonists of adenosine receptors. The derivatives and compositions are used to treat conditions, including certain cardiac arrhythmias. The compounds, specifically, are C-8 epoxide derivatives of xanthine having the general formulae of: ##STR1## wherein R.sub.1 and R.sub.2 are the same or different, and can be H or an alkyl group of 1-4 carbons, and n=0-4; and ##STR2## wherein R.sub.1 and R.sub.2 are the same or different, and can be H or an alkyl group of 1-4 carbons, R.sub.3 is either O or (CH.sub.2).sub.1-4, and n=0-4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.